Literature DB >> 7513433

Rapid induction of messenger RNA for nitric oxide synthase II in rat neutrophils in vivo by endotoxin and its suppression by prednisolone.

J Kolls1, J Xie, R LeBlanc, T Malinski, S Nelson, W Summer, S S Greenberg.   

Abstract

Nitric oxide is believed to participate in nonspecific cellular immunity. Gram negative bacterial endotoxins increase the production of reactive nitrogen intermediates (RNI) in phagocytic cells by inducing the enzyme nitric oxide synthase II (NOS II). Anti-inflammatory glucocorticoids attenuate endotoxin-induced increases in RNI. This study evaluated the effect of in vivo administration of prednisolone on Escherichia coli lipopolysaccharide endotoxin (LPS)-induced increases in plasma RNI and neutrophil mRNA for NOS II and production of RNI in the rat. We show that LPS rapidly induces mRNA for NOS II and production of RNI (NO2- and NO3- anion) in rat neutrophils within 2 hr after in vivo administration of a sublethal dose of 0.5 mg/kg, i.v. A pharmacologic dose of prednisolone (50 micrograms/kg, im) given 15 min before LPS-attenuated production of NO2- and NO3- by neutrophils and suppressed LPS-stimulated mRNA for NOS II. 3-Amino, 1,2,4-triazine inhibited NO2- and NO3- production without affecting gene expression for NOS II. These data demonstrate that LPS rapidly induces functional gene expression for NOS II and prednisolone prevents induction of NOS II activity by inhibiting transcription of its mRNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513433     DOI: 10.3181/00379727-205-43700

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  10 in total

1.  Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria.

Authors:  T J Evans; L D Buttery; A Carpenter; D R Springall; J M Polak; J Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 2.  Neutrophil migration under normal and sepsis conditions.

Authors:  Yelena V Lerman; Minsoo Kim
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2015

3.  Nitric oxide production by rat bronchoalveolar macrophages or polymorphonuclear leukocytes following intratracheal instillation of lipopolysaccharide or silica.

Authors:  L J Huffman; D J Prugh; L Millecchia; K C Schuller; S Cantrell; D W Porter
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

4.  Protective effect of L-ascorbic acid against oxidative damage in the liver of rats with water-immersion restraint stress.

Authors:  Shingo Kaida; Yoshiji Ohta; Yoichiro Imai; Minoru Kawanishi
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

5.  The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats.

Authors:  Mustafa Paksoy; Emin Ayduran; Arif Sanlı; Mehmet Eken; Sedat Aydın; Zeynep Alev Oktay
Journal:  Med Oncol       Date:  2010-03-19       Impact factor: 3.064

6.  The involvement of nitric oxide in the anti-Candida albicans activity of rat neutrophils.

Authors:  I M Fierro; C Barja-Fidalgo; F Q Cunha; S H Ferreira
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

7.  Expression and localization of inducible nitric oxide synthase in anti-Thy-1 glomerulonephritis.

Authors:  S Goto; T Yamamoto; L Feng; E Yaoita; S Hirose; H Fujinaka; K Kawasaki; R Hattori; Y Yui; C B Wilson
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

8.  Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections.

Authors:  Gerhard W Hill; D Kent Morest; Kourosh Parham
Journal:  Otol Neurotol       Date:  2008-10       Impact factor: 2.311

9.  Anti-apoptotic effect of dexamethasone in an ototoxicity model.

Authors:  Jin Ho Lee; Se Heang Oh; Tae Ho Kim; Yoon Young Go; Jae-Jun Song
Journal:  Biomater Res       Date:  2017-04-06

10.  Effect of Dexamethasone Combination with Gentamicin in Chemical Labyrinthectomy on Hearing Preservation and Vertigo Control in Patients with Unilateral Meniere's Disease: A Randomized Controlled Clinical Trial.

Authors:  Seong-Hoon Bae; Jeon-Mi Lee; Hyun-Jin Lee; Gina Na; Sung-Huhn Kim
Journal:  J Clin Med       Date:  2021-11-27       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.